Spend less to achieve more: Economic analysis of intermittent versus continuous cetuximab in KRAS wild-type patients with metastatic colorectal cancer

Autor: Henderson, Raymond H., French, Declan, McFerran, Ethna, Adams, Richard, Wasan, Harpreet, Glynne-Jones, Robert, Fisher, David, Richman, Susan, Dunne, Philip D., Wilde, Lisa, Maughan, Timothy S., Sullivan, Richard, Lawler, Mark
Zdroj: In Journal of Cancer Policy September 2022 33
Databáze: ScienceDirect
Externí odkaz: